CTLT Catalent Inc

  1. Stocks
  2. Healthcare
  3. NYSE: CTLT

Price (delayed)

$55.48

Market cap

$10.03B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.19

Enterprise value

$14.8B

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It ...

Highlights
Catalent's quick ratio has soared by 51% from the previous quarter and by 13% YoY
Catalent's gross profit has plunged by 52% YoY and by 23% from the previous quarter
Catalent's gross margin has decreased by 45% YoY and by 20% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: SUPN JAZZ EGRX TBPH

Key stats

What are the main financial stats of CTLT
Market
Shares outstanding
180.74M
Market cap
$10.03B
Enterprise value
$14.8B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.72
Price to sales (P/S)
2.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.61
Earnings
Revenue
$4.1B
EBIT
-$1.21B
EBITDA
-$754M
Free cash flow
-$261M
Per share
EPS
-$7.19
Free cash flow per share
-$1.44
Book value per share
$20.41
Revenue per share
$22.69
TBVPS
$37.23
Balance sheet
Total assets
$9.99B
Total liabilities
$6.3B
Debt
$5.01B
Equity
$3.69B
Working capital
$1.53B
Liquidity
Debt to equity
1.36
Current ratio
2.48
Quick ratio
1.03
Net debt/EBITDA
-6.33
Margins
EBITDA margin
-18.4%
Gross margin
17.9%
Net margin
-31.8%
Operating margin
-29.3%
Efficiency
Return on assets
-12.5%
Return on equity
-30.9%
Return on invested capital
-12%
Return on capital employed
-13.5%
Return on sales
-29.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CTLT stock price

How has the Catalent stock price performed over time
Intraday
-0.57%
1 week
-1.46%
1 month
-0.84%
1 year
28.81%
YTD
23.48%
QTD
-1.72%

Financial performance

How have Catalent's revenue and profit performed over time
Revenue
$4.1B
Gross profit
$735M
Operating income
-$1.2B
Net income
-$1.3B
Gross margin
17.9%
Net margin
-31.8%
Catalent's gross profit has plunged by 52% YoY and by 23% from the previous quarter
Catalent's gross margin has decreased by 45% YoY and by 20% from the previous quarter
The net margin has contracted by 33% from the previous quarter
Catalent's operating margin has decreased by 30% from the previous quarter

Growth

What is Catalent's growth rate over time

Valuation

What is Catalent stock price valuation
CTLT P/E details
P/E
N/A
P/B
2.72
P/S
2.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.61
The company's EPS fell by 28% QoQ
The price to book (P/B) is 30% higher than the last 4 quarters average of 2.1 but 28% lower than the 5-year quarterly average of 3.8
CTLT's equity is down by 25% year-on-year and by 4% since the previous quarter
CTLT's price to sales (P/S) is 28% lower than its 5-year quarterly average of 3.4 but 17% higher than its last 4 quarters average of 2.1
The revenue has declined by 13% year-on-year and by 3% since the previous quarter

Efficiency

How efficient is Catalent business performance
Catalent's return on equity has decreased by 37% QoQ
The company's return on sales fell by 34% QoQ
The company's return on assets fell by 32% QoQ
CTLT's return on invested capital is down by 28% since the previous quarter

Dividends

What is CTLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CTLT.

Financial health

How did Catalent financials performed over time
Catalent's total assets is 59% more than its total liabilities
Catalent's quick ratio has soared by 51% from the previous quarter and by 13% YoY
The current ratio is up by 46% since the previous quarter and by 30% year-on-year
The debt is 36% more than the equity
The company's debt to equity rose by 37% YoY and by 5% QoQ
CTLT's equity is down by 25% year-on-year and by 4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.